Achieving asthma control remains an elusive goal for the majority of patients worldwide.
Ensuring a correct diagnosis of asthma is the first step in assessing poor symptom control; this …

Recommendations in asthma guidelines presuppose that practitioners have the evidence,
information, knowledge, and tools to select inhaler devices appropriate for individual patients. …

Background Clinical trials show that asthma can be controlled in the majority of patients, but
poorly controlled asthma still imposes a considerable burden. The level of asthma control …

Background Few data exist on the comparative safety and immunogenicity of different
COVID-19 vaccines given as a third (booster) dose. To generate data to optimise selection of …

Background Some high-income countries have deployed fourth doses of COVID-19 vaccines,
but the clinical need, effectiveness, timing, and dose of a fourth dose remain uncertain. We …

Vaccination-based exposure to spike protein derived from early SARS-CoV-2 sequences is
the key public health strategy against COVID-19. Successive waves of SARS-CoV-2 …

Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone of the public health
response to COVID-19. The emergence of hypermutated, increasingly transmissible variants …

Vaccines are proving to be highly effective in controlling hospitalisation and deaths
associated with SARS-CoV-2 infection but the emergence of viral variants with novel antigenic …

Study objectives This study was conducted to gain insight into patients’ comprehension,
recognition, and experience of exacerbations of COPD, and to explore the patient burden …

Background Asthma is a heterogeneous disease in which there is a differential response to
asthma treatments. This heterogeneity needs to be evaluated so that a personalized …